Hot Keywords
rare disease orphan drug

Top

Editorial Board

Editor-in-Chief

Associate Editor

  • Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

Editorial Board Members

  • RDM Cardiovascular Medicine, Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
  • Service de pharmacologie clinique et pharmacovigilance, Aix Marseille Université, AP-HM, Orphandev-FCRIN, INSERM, Marseille, France.
  • SquareRootThinking and EURORDIS - Rare Diseases Europe, Paris, France.
  • Department of Human Genetics and Donders Center for Neuroscience, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • Genethon, INSERM, Université Evry Val-d’Essone, Université Paris-Saclay, Evry, France.
  • Department of Nephrology-Transplantation, Necker Hospital, APHP, Paris, France.
  • Institute of Rare Diseases Research (IIER), Instituto de Salud Carlos III, Madrid, Spain.
  • Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Translational Neuroscience Facility and Department of Physiology, School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia.
  • Museum National d'Histoire Naturelle, Inserm, Sorbonne Universités, Paris, France.
  • Faculté de Pharmacie de Paris, Université de Paris, Paris, France.
  • The Mina and Everard Goodman Faculty of Life Sciences, Advanced Materials and Nanotechnology Institute, Bar-Ilan University, Ramat Gan, Israel.
  • EURORDIS-Rare Diseases Europe, Paris, France.
  • Translational Neuroscience Facility and Department of Physiology, School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
  • Department of Cell Biology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Institute for Genomic Statistics and Bioinformatics, University of Bonn, Bonn, Germany.
  • Université Paris-Dauphine, PSL Research University, Paris, France.
  • School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.
  • Medicines and Healthcare products Regulatory Agency , Canary Wharf, London, United Kingdom.
  • Department of Pediatrics, Sanford School of Medicine, University of South Dakota, Sioux Falls, South Dakota, United States.
  • Division of Nephrology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
  • Catalan Institution of Research and Advanced Studies (ICREA), Barcelona, Catalonia, Spain.
  • The Institute for Rare Diseases, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan, Israel.
  • The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, United States.
  • Medicines Evaluation Board, Utrecht, The Netherlands.
  • Division of Ophthalmology, Department of Clinical Neurosciences, Geneva University Hospitals, Geneva, Switzerland.
  • Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
© 2016-2021 OAE Publishing Inc., except certain content provided by third parties